Description

Ozagrel Sodium is a selective thromboxane A2 (TXA2) synthase inhibitor, a high-purity active pharmaceutical ingredient (API) with significant therapeutic potential. Its primary value lies in its ability to prevent platelet aggregation and vasoconstriction, making it a critical compound for research and development in cardiovascular and cerebrovascular medicine. This product is essential for pharmaceutical manufacturers, research institutions, and biotechnology companies focused on developing anti-thrombotic and neuroprotective agents.

Application

• Active Pharmaceutical Ingredient (API) in the formulation of antiplatelet medications.
• Key intermediate in advanced pharmaceutical research for treating ischemic stroke and cerebral thrombosis.
• Reference standard for analytical method development and quality control in pharmaceutical laboratories.
• Biochemical research tool for studying the thromboxane A2 pathway and platelet physiology.
• Preclinical development of novel therapeutics for cardiovascular diseases.
• Manufacturing of finished dosage forms such as injections, under cGMP conditions.

Basic Information

Product Name	Ozagrel Sodium
CAS No.	130952-46-4
Molecular Formula	C13H11N2NaO2
Molecular Weight	250.23 g/mol
Synonyms	Ozagrel Sodium Salt; (E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic Acid Sodium Salt; OKY-046 Sodium; Sodium (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]acrylate; Cataclot; Xanbon; 130952-46-4; Ozagrel Na
EINECS	Contact for details

Quality Control

Our Ozagrel Sodium is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity standards suitable for pharmaceutical applications. A detailed Certificate of Analysis (COA) is provided with every shipment, confirming identity, purity, and conformance to agreed specifications. We support compliance with cGMP, ICH Q7, and other relevant pharmaceutical guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference standard
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.